Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    Generic product launch announcement: can we mention the original brand name?

    Claims & Support/References for Claims
    2
    4
    137
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • A
      akar last edited by

      Can a generic company make mention of the original brand name in their launch announcement communication to HCPs? We would like to explore two scenarios: one in which the original brand is no longer manufactured and our communication announces the launch of a generic so that docs can keep their patients on the same pill as the original molecule and a scenario in which the original brand is still available for purchase?

      1 Reply Last reply Reply Quote 0
      • Jennifer Carroll
        Jennifer Carroll last edited by

        This post is deleted!
        1 Reply Last reply Reply Quote 0
        • A
          akar last edited by

          This post is deleted!
          1 Reply Last reply Reply Quote 0
          • Jennifer Carroll
            Jennifer Carroll last edited by

            @akar Great question.

            Note that any of the proposed content would require review under the PAAB code. This is occasionally a point of confusion in the generic space.

            If the generic product’s TMA refers to the innovator brand as the reference product, the generic manufacturer may convey this fact in the APS. For example, “… generic version of Drug X [the reference product]”.

            In the unlikely event that the reference product is no longer authorized for sale, this should be conveyed through a cross-reference to the claim above. However, a manufacturer should only discuss the availability status of its own products. For example, it would be unacceptable to comment on a competitor’s drug shortage issues.

            Any messages relating to switching will require support from the TMA or standard setting organizations.

            1 Reply Last reply Reply Quote 0
            • First post
              Last post